Matches in Wikidata for { <http://www.wikidata.org/entity/Q91926670> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q91926670 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q91926670 description "scientific article published on 26 February 2019" @default.
- Q91926670 description "wetenschappelijk artikel" @default.
- Q91926670 description "наукова стаття, опублікована в лютому 2019" @default.
- Q91926670 name "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 name "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 type Item @default.
- Q91926670 label "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 label "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 prefLabel "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 prefLabel "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 P1433 Q91926670-287BFDD5-CD8B-478A-9196-9D4973A863E7 @default.
- Q91926670 P1476 Q91926670-04FDC038-8D17-4F5E-95EA-EE0031605CF2 @default.
- Q91926670 P2093 Q91926670-8B737FF8-E8C1-43AA-8BC9-C7479804F359 @default.
- Q91926670 P2093 Q91926670-8D060191-302F-4BE0-83BC-8BA4E2B7CA25 @default.
- Q91926670 P304 Q91926670-DC9021A9-FDAB-4F4A-A6D5-E02920676595 @default.
- Q91926670 P31 Q91926670-CEAD92A5-95B9-4D33-A0BC-26A591F6613D @default.
- Q91926670 P356 Q91926670-6FED4396-5DF2-4F61-8863-292ADD0D529C @default.
- Q91926670 P433 Q91926670-500D313D-C41A-4ABC-AB7D-E0E45850AB59 @default.
- Q91926670 P478 Q91926670-88A18000-A63E-431B-AE04-9C62CE7DF93B @default.
- Q91926670 P50 Q91926670-0C64B896-D8FD-4A39-A32B-9791BAD884D9 @default.
- Q91926670 P50 Q91926670-E47B461B-2398-49A5-AAA0-46B63233E168 @default.
- Q91926670 P577 Q91926670-CFC4787C-705E-4C85-9FEB-63EEB6BCE716 @default.
- Q91926670 P698 Q91926670-3AE42BFA-DD8D-4BB6-AB0E-F31D33185881 @default.
- Q91926670 P921 Q91926670-15833227-45A6-418E-A4FD-009E9CF80819 @default.
- Q91926670 P921 Q91926670-776EE2D6-C301-470E-B5CD-5314D5159235 @default.
- Q91926670 P356 S10637-019-00743-1 @default.
- Q91926670 P698 30806848 @default.
- Q91926670 P1433 Q2312231 @default.
- Q91926670 P1476 "Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma" @default.
- Q91926670 P2093 "A Hulin" @default.
- Q91926670 P2093 "G Beinse" @default.
- Q91926670 P304 "1289-1291" @default.
- Q91926670 P31 Q13442814 @default.
- Q91926670 P356 "10.1007/S10637-019-00743-1" @default.
- Q91926670 P433 "6" @default.
- Q91926670 P478 "37" @default.
- Q91926670 P50 Q63372367 @default.
- Q91926670 P577 "2019-02-26T00:00:00Z" @default.
- Q91926670 P698 "30806848" @default.
- Q91926670 P921 Q1164529 @default.
- Q91926670 P921 Q19000948 @default.